Browse > Article

Effects of Epigallocatechin Gallate on the Bioavailability of Nimodipine after Oral and Intravenous Administration in Rats  

Lee, Chong-Ki (Department of Medical Management, Chodang University)
Choi, Jun-Shik (College of Pharmacy, Chosun University)
Choi, Dong-Hyun (College of Medicine, Chosun University)
Publication Information
YAKHAK HOEJI / v.55, no.4, 2011 , pp. 332-337 More about this Journal
Abstract
The purpose of this study was to investigate the effect of epigallocatechin gallate (EGCG) on the pharmacokinetics of nimodipine in rats. Pharmacokinetic parameters of nimodipine were determined in rats after oral and iv administration of nimodipine with or without EGCG and also the effect of EGCG on the cytochrome P450 (CYP) 3A4 and P-glycoprotein (P-gp) activity were evaluated. EGCG inhibited CYP3A4 and P-gp activity. EGCG significantly increased the area under the plasma concentration-time curve (AUC) and peak plasma concentration ($C_{max}$) of nimodipine. The absolute bioavailability (AB%) and relative bioavailability (RB%) of nimodipine by EGCG were increased by 16% and by 48%, respectively, compared to the control. In contrast, EGCG did not affect the intravenous pharmacokinetics of nimodipine. Based on these results, the increased bioavailability of nimodipine might be due to inhibition of CYP3A4 in the small intestine and/or in the liver and inhibition of P-gp in the small intestine by EGCG.
Keywords
nimodipine; epigallocatechin gallate; bioavailability; pharmacokinetics; CYP3A4; P-gp; rats;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ramsch, K. D., Ahr, G., Tettenborn, D. and Auer, L. M. : Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage. Neurochirurgia. 28, 74 (1985).
2 Scherling, D., Buhner, K., Krause, H. P., Karl, W. and Wünsche, C. : Biotransformation of nimodipine in rat, dog, and monkey. Arzneimittelforschung. 41, 392 (1991).
3 Guengerich, F. P., Brian, W. R., Iwasaki, M., Sari, M. A., Bäärnhielm, C. and Berntsson, P. : Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrom P-450 IIIA4. J. Med. Chem. 34, 1834 (1991).
4 Maruhn, D., Siefert, H. M., Weber, H., Rämsch, K. and Suwelack, D. : Pharmacokinetics of nimodipine. I. communication: absorption, concentration in plasma and excretion after single administration of [14C] nimodipine in rat, dog and monkey. Arzneimittelforschung. 35, 1781 (1985).
5 Suwelack, D., Weber, H. and Maruhn, D. : Pharmacokinetics of nimodipine, II. communication: absorption, concentration in plasma and excretion after single administration of [14C] nimodipine in rat, dog and monkey. Arzneimittelforschung. 35, 1787 (1985).
6 Rahman, A., Korzekwa, K. R., Grogan, J., Gonzalez, F. J. and Harris, J. W. : Selective biotransformation of taxol to 6 alphahydroxytaxol by human cytochrome P450 2C8. Cancer Res. 54, 5543 (1994).
7 Scholz, H. : Pharmacological aspects of calcium channel blockers. Cardiovasc. Drugs Ther. 10, 869 (1997).   DOI   ScienceOn
8 Epstein, M. and Loutzenhister, R. D. : Effects of calcium antagonists on renal hemodynamics. Am. J. Kidney. Dis. 16, 10 (1990).
9 Wacher, V. J., Wu, C. Y. and Benet, L. Z. : Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 13, 129 (1995).   DOI   ScienceOn
10 Kazda, S., Garthoff, B., Krause, H. P. and Schlossmann, K. : Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. Arzneimittelforschung. 32, 331 (1982).
11 Zhang, D. M., He, Z. W., Liu, X. D., Li, Y., Xie, L., Wang, G. J. and Liu, L. : In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier. J. Pharm. Pharmacol. 59, 1733 (2007).   DOI   ScienceOn
12 Sandstrom, R., Karlsson, A., Knutson, L. and Lennernas H. : Jejunal absorption and metabolism of R/S-verapamil in humans. Pharm. Res. 15, 856 (1998).   DOI   ScienceOn
13 Kitagawa, S., Nabekura, T. and Kamiyama, S. : Inhibition of Pglycoprotein function by tea catechins in KB-C2 cells. J.Pharm. Pharmacol. 56, 1001 (2004).   DOI   ScienceOn
14 Endicott, J. A. and Ling, V. : The biochemistry of P-glycoprotein mediated multidrug resistance. Ann. Rev. Biochem. 58, 137 (1989).   DOI   ScienceOn
15 Zhang, H., Wong, C. W., Coville, P. G. and Wanwimolruk, S. : Effect of the grapefruit flavonoid naringen on pharmacokinetics of quinine in rats. Drug Metabol. Drug Interact. 17, 351 (2000).
16 Kumar, G. N., Walle, U. K. and Walle, T. : Cytochrome P450 3A-mediated human liver microsomal taxol to 6 alphahydroxylation. J. Pharmacol. Exp. Ther. 268, 1160 (1994).
17 Crespi, C. L., Miller, V. P. and Penman, B. W. : Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248, 188 (1997).   DOI   ScienceOn
18 Soambia, G., Ranellett, F. O., Panici, P. B., De Vincenzo, R., Bonanno, G., Frrandina, G., Piantelli, M., Bussa, S., Rumi, C., Ciantriglia, M. and Mancuso, S. : Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 36, 448 (1995).   DOI   ScienceOn
19 Choi, C. H., Romiti, N., Cervelli, F. and. Tongiani, R. : Effect of flavonols on P-glycoprotein activety in cultured rat hepatocytes. Life Sci. 57, 1741 (1995).   DOI   ScienceOn
20 Hong, J., Lambert, J. D., Lee, S. H., Sinko, P. J. and. Yang, C. S. : Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem. Biophys. Res. Commun. 310, 222 (2003).   DOI   ScienceOn
21 Qian, M. and Gallo, J. M. : High-performance liquid chromatographic determination of the calcium channel blocker nimodipine in monkey plasma. J. Chromatogr. 578, 316 (1992).   DOI
22 Zhang, L., Liu, X. D., Xie, L. and Wang, G. J. : P-glycoprotein restricted transport of nimodipine across blood-brain barrier. Acta. Pharmacol. Sin. 24, 903 (2003).
23 Jodoin, J., Demeule, M. and Beliveau, R. : Inhibition of the mutldrug resistance P-glycoprotein activity by green tea polyphenols. Biochim. Biophys. Acta. 1542, 149 (2002).   DOI   ScienceOn
24 Muto, S., Fujita, K., Yamazaki, Y. and Kamataki, T. : Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 479, 197 (2001).   DOI
25 Chu, D. C. and Juneja, L. R. : Chemistry and Applications of Green Tea, in: T. Yamamoto, L. R. Juneja, D. C. Chu and M. Kim, (Eds.), CRC Press, New York, pp. 1322 (1997).
26 Higdon, J. V. and Frei, B. : Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43, 89 (2003).   DOI   ScienceOn
27 Kuroda, Y. and Hara, Y. : Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. 436, 69 (1999).   DOI   ScienceOn
28 Fuhr, U., Maier-Bruggemann, A., Blume, H., Mück, W., Unger, S., Kuhlmann, J., Huschka, C., Zaigler, M., Rietbrock, S. and Staib, A. H. : Grapefruit juice increases oral nimodipine bioavailability. Int. J. Clin. Pharmacol. Ther. 36, 126 (1998).